Literature DB >> 6692466

Growth and vascular structure of human melanoma xenografts.

E K Rofstad.   

Abstract

The growth and the vascular structure of five human melanomas grown in athymic nude mice were studied. Four growth parameters (tumour volume doubling time, fraction of cells in S-phase, growth fraction, cell-loss factor) were analysed against each of four vascular parameters (length of vessels with diameters in the range 5-15 micron, total vessel length, total vessel surface, total vessel volume--all per unit of histologically intact tumour volume). Statistically significant linear correlations between the parameters were found for any of the combinations. However, there was a consistent trend in the data: the tumour volume doubling time and the cell-loss factor tended to decrease while the fraction of cells in S-phase and the growth fraction tended to increase with increasing vascular density, whichever vascular parameter was considered. This finding indicates that the vascular density is among the factors which are decisive for the growth rate of tumours. However, the present work does not exclude the possibility that intrinsic properties of the tumour cells may also be important.

Entities:  

Mesh:

Year:  1984        PMID: 6692466     DOI: 10.1111/j.1365-2184.1984.tb00571.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  11 in total

1.  Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.

Authors:  R O Schlingemann; F J Rietveld; F Kwaspen; P C van de Kerkhof; R M de Waal; D J Ruiter
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

Authors:  S S Brem; D Zagzag; A M Tsanaclis; S Gately; M P Elkouby; S E Brien
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

3.  Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging.

Authors:  W Mueller-Klieser; S Walenta
Journal:  Histochem J       Date:  1993-06

4.  Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.

Authors:  S W McLeskey; C A Tobias; P R Vezza; A C Filie; F G Kern; J Hanfelt
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.

Authors:  A Srivastava; P Laidler; R P Davies; K Horgan; L E Hughes
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

6.  Effects of oxygen tension on tumor colony formations assessed by human tumor clonogenic assay.

Authors:  N Hirabayashi; M Nishiyama; M Yamaguchi; Y Nosoh; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1986-03

7.  Critical evaluation of histochemical and immunochemical methods for the demonstration of vascular supply in rectal and oesophageal cancer.

Authors:  R Porschen; C Langen; A Kriegel; B Lohe; F Borchard
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

8.  Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours.

Authors:  E K Rofstad; R M Sutherland
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

9.  Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity.

Authors:  E K Rofstad; T Brustad
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

10.  Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).

Authors:  E O Pettersen; R O Larsen; J M Dornish; B Børretzen; M E Juul; T E Aastveit; J M Nesland; E K Rofstad; R Oftebro
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.